Orthopaedic Product News & Orthopaedic Press Releases | Orthogate Professionals

curasan AG presented innovative medical products from the Cerasorb^® umbrella brand at the 57th annual congress of the Association of South-German Orthopaedic Surgeons (Vereinigung Süddeutscher Orthopäden e. V.) - Report on experiences with the use of Cerasorb^® M during revision operations to correct acetabular cup loosening in the hip joint: use of Cerasorb^® M for filling of defects successful in 30 older patients - Low risk of infection documented

Online patient communities and patient forums have sprouted up all across the web, focusing on diseases and conditions ranging from total hip surgery, to insomnia, to epilepsy and cancer.  For the most part, these forums serve as a reliable source of medical information and the benefits of them are becoming clearer with time.

Online patient communities and patient forums have sprouted up all across the web, focusing on diseases and conditions ranging from total knee surgery, to insomnia, to epilepsy and cancer.  For the most part, these forums serve as a reliable source of medical information and the benefits of them are becoming clearer with time.

Online patient communities and patient forums have sprouted up all across the web, focusing on diseases and conditions ranging from total hip surgery, to obesity, to heart surgery and cancer.  For the most part, these forums serve as a reliable source of medical information and the benefits of them are becoming clearer with time.

Online patient communities and patient forums have sprouted up all across the web, focusing on diseases and conditions ranging from insomnia, to epilepsy, to cancer, and joint replacement surgery.  For the most part, these forums serve as a reliable source of medical information and the benefits of them are becoming well documented.

Outstanding suitability of Cerasorb^® M for tissue engineering - Studies confirm positive results regarding the colonisation of Cerasorb^® M with various types of cells - curasan AG intends to provide support to embryonic stem cell research with the highly suitable substrate Cerasorb^® M

EnBIO today launched its OsteoZip^TM surface, which has been designed to enhance the osteointegration and early bone fixation of orthopedic implants into host bone tissue. OsteoZip is a revolutionary new hydroxyapatite (HA) surface that is ideal for orthopedic and dental implants. Applied and enabled by EnBIO's CoBlast^TM surface modification process, OsteoZip heralds a new era of functional surfaces for orthopedic implants. The CoBlast process is non-complex, room temperature and requires no wet chemistry, providing orthopedic implant OEMs with a state-of-the-art surface at a competitive cost. The CoBlast process is in fact a novel variation of grit-blasting-a well practiced process in the medical device industry-and the CoBlast processing equipment is essentially a modified version of standard grit blasting equipment.